3% Hypertonic saline vs normal saline nebulization in children with acute bronchiolitis. Critical appraisal of an article "Hypertonic (3%) saline vs 0.9% saline nebulization for acute viral bronchiolitis: A randomized controlled trial.

被引:2
|
作者
Yadav, Krishna K. [1 ]
机构
[1] King George Med Univ, Dept Pediat, Lucknow 226003, Uttar Pradesh, India
来源
关键词
Critical appraisal; 3% Saline nebulization; Bronchiolitis; Consort; 2010;
D O I
10.1016/j.cegh.2014.01.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Question: Nebulization with hypertonic saline have been shown to be effective in management of acute bronchiolitis in different studies. In the present study duration of hospital stay and clinical severity scores of children admitted with acute bronchiolitis were compared between two groups. One group received nebulization with 3% hypertonic saline while other group received nebulization with 0.9% normal saline. Methods: This study was a double blinded randomized controlled trial conducted in a tertiary care teaching hospital in Jaipur, India from September 2009 to December 2010. Study population included 250 hospitalized children aged 1-24 months with clinical diagnosis of acute bronchiolitis of moderate severity as assessed by clinical severity score proposed by Wang et al. The study population was randomized into two groups to receive either nebulization of 4 ml of 3% hypertonic saline or 4 ml of 0.9% saline, along with 2.5 mg salbutamol in both groups, at 4 hourly intervals till the patients were fit for discharge. Fitness for discharge was defined by authors as "feeding well, no need of IV fluids and oxygen therapy, clinical severity scores <= 3, absence of accessory muscle use or tachypnoea (respiratory rate < 31 breaths/min) and oxygen saturation > 92% on air". Main results: The results of the study were in three forms viz baseline characteristics, duration of hospital stay and improvement in clinical severity scores between above two groups. Baseline characteristics were similar in both groups. The clinical severity scores were recorded at the time of recruitment and twelve hourly thereafter till discharge. The median clinical severity scores of the two groups were similar at the time of recruitment and thereafter in two groups. The duration of hospital stay was 63.93 +/- 22.43 h in 3% saline group which was similar to 63.51 +/- 21.27 h in 0.9% saline group (P = 0.878). None of parents, caregivers or treating physicians were reported any adverse events in both groups. Conclusion: Nebulization with 0.9% normal saline or 3% hypertonic saline has got similar efficacy in terms of duration of hospital stay and improvement in clinical severity scores among the children admitted with acute bronchiolitis. Copyright (C) 2014, INDIACLEN. Publishing Services by Reed Elsevier India Pvt Ltd. All rights reserved.
引用
收藏
页码:141 / 142
页数:2
相关论文
共 50 条
  • [41] Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
    Gaëlle Beal
    Catherine Barbier
    Sophie Thoret
    Amandine Rubio
    Mathilde Bonnet
    Roseline Mazet
    Anne Ego
    Isabelle Pin
    BMC Pediatrics, 19
  • [42] Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
    Beal, Gaelle
    Barbier, Catherine
    Thoret, Sophie
    Rubio, Amandine
    Bonnet, Mathilde
    Mazet, Roseline
    Ego, Anne
    Pin, Isabelle
    BMC PEDIATRICS, 2019, 19 (01)
  • [43] A randomized clinical trial to assess the effect of zinc and vitamin D supplementation in addition to hypertonic saline on treatment of acute bronchiolitis
    Parisa Khoshnevisasl
    Mansour Sadeghzadeh
    Koorosh Kamali
    Armita Ardalani
    BMC Infectious Diseases, 22
  • [44] A randomized clinical trial to assess the effect of zinc and vitamin D supplementation in addition to hypertonic saline on treatment of acute bronchiolitis
    Khoshnevisasl, Parisa
    Sadeghzadeh, Mansour
    Kamali, Koorosh
    Ardalani, Armita
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [45] Influence of 3% Hypertonic Saline vs 0.9% Saline on Maintenance Fluid Requirements in Adult Patients Undergoing Major Abdominal Surgeries: Randomized Triple-Blind Trial
    Misra, Satyajeet
    Behera, Sri Hari Priya
    Behera, Bikram K.
    ANESTHESIA AND ANALGESIA, 2021, 132 (5S_SUPPL): : 922 - 922
  • [46] Bolus therapy with 3% hypertonic saline or 0.9% saline in emergency department patients with suspected sepsis: A pilot randomised controlled trial
    Smart, Lisa
    Macdonald, Stephen P. J.
    Bosio, Erika
    Fatovich, Daniel
    Neil, Claire
    Arendts, Glenn
    JOURNAL OF CRITICAL CARE, 2019, 52 : 33 - 39
  • [47] Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: A randomized control trial
    Anuradha, Kodippilikande W. D. A.
    Gunathilaka, Paththini K. Ganganath
    Wickramasinghe, Vithanage P.
    PEDIATRIC PULMONOLOGY, 2021, 56 (02) : 509 - 515
  • [48] Effects of hypertonic saline (7.5%) on lactate clearance compared with normal saline (0.9%) after on pump cardiovascular surgery. a randomized controlled trial
    LH Atehortua Lopez
    R Mendoza
    A Urrego
    JF Escobar
    FA Jaimes Barragan
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [49] Effect of 3% Hypertonic Saline Resuscitation on Lactate Clearance and Its Comparison With 0.9% Normal Saline in Traumatic Injury Patients: A Prospective Randomized Control Trial
    Meena, Kavita
    Gautam, Suprabhat
    Kyizom, Tenzin
    Meena, Rajesh K.
    Nayak, Aditya P.
    Prakash, Shashi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [50] Late-breaking abstract: Hypertonic saline in acute bronchiolitis: Randomised controlled trial (RCT) and economic evaluation (the SABRE study)
    Everard, Mark L.
    Hind, Daniel
    Freeman, Jennifer V.
    Bradburn, Mike
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44